Financial Highlights and Forward Looking Strategy
Standalone Financial Performance
Comparison - H1 FY20 v/s H1 FY21
26
The total Revenue from operations
declined by 32% from 5,798.67 mn in
H1 FY20 to 3,929.15 mn in H1 FY21
Cost of material reduced by 30% from
3,669.56 mn in H1 FY20 to
2,553.02 mn in H1 FY21
EBITDA declined by 78% from * 803.00
mn in H1 FY20 to 177.75 mn in H1
FY21 and EBITDA margins reduced
from 13.67% in H1 FY20 to 4.37% in H1
FY21
Net profit stood at 11.55 mn in
H1 FY21, compared to
H1 FY20
Current Assets stood at
in H1 FY21, compared to
mn in H1 FY20
527.69 Mn in
4,836.30 mn
5,456.05
Current Liabilities stood at
3,290.06 mn in H1 FY21, compared
to 4,030.39 mn in H1 FY20
Finance Cost reduced by 22% from
56.82 mn in H1 FY20 to 44.51 mn
in H1 FY21
Net Cash flow from operations
increased from -15.05 mn in H1 FY20
to 79.26 mn in H1 FY21
K
Bodal Chemicals Ltd."
www.bodal.comView entire presentation